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Abstract
Mutations in the DJ-1 gene have been linked to autosomal recessive familial Parkinson's disease. To
understand the function of DJ-1, we determined the DJ-1 expression in both zebrafish and post
mortem human brains. We found that DJ-1 was expressed early during zebrafish development and
throughout adulthood. Knock down (KD) of DJ-1 by injection of morpholino did not cause
dramatic morphologic alterations during development, and no loss of dopaminergic neurons was
observed in embryos lacking DJ-1. However, DJ-1 KD embryos were more susceptible to
programmed cell death. While a slight reduction in staining for islet-1 positive neurons was
observed in both DJ-1 KD and H2O2 treated embryos, the number of apoptotic cells was
significantly increased in both KD and H2O2 treated embryos. Interestingly, DJ-1 expression was
increased in brains of zebrafish under conditions of oxidative stress, indicating that DJ-1 is a part
of stress-responsive machinery. Since oxidative stress is one of the major contributors to the
development of Alzheimer's disease (AD), we also examined DJ-1 expression in AD brains. Using
DJ-1 specific antibodies, we failed to detect a robust staining of DJ-1 in brain tissues from control
subjects. However, DJ-1 immunoreactivity was detected in hippocampal pyramidal neurons and
astrocytes of AD brains. Therefore, our results strongly suggest that DJ-1 expression is not
necessary during zebrafish development but can be induced in zebrafish exposed to oxidative stress
and is present in human AD brains.
Background
Parkinson's disease (PD) and Alzheimer's disease (AD)
are the two most common neurodegenerative disorders.
PD is characterized by loss of dopaminergic (DA) neurons
in the substantia nigra and accumulation of intraneuronal
inclusions known as Lewy bodies. AD is characterized by
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plaques. Genetic studies of PD have demonstrated that
two autosomal dominant genes (α-synuclein and LRRK2)
[1-3] and three autosomal recessive genes (Parkin, PINK1,
and DJ-1) are linked to PD [4-6]. Earlier reports indicate
that DJ-1 is expressed in astrocytes and neurons in both
control and PD brains, and it is not a major component of
Lewy bodies, the pathological hallmark of PD [7,8]. Inter-
estingly, DJ-1 has been reported to co-localize with Tau in
neurofibrillary tangles from brains of AD patients, sug-
gesting that PD-linked DJ-1 may play a role in AD [8,9].
Recent studies have found that DJ-1 is enriched in brain
tissue containing insoluble hyperphosphorylated tau
[10]. In addition, accumulation of acidic isoforms of DJ-1
monomers [10] and basic isoforms of DJ-1 dimers [11]
have been found in brains of PD and AD brains. These
studies have shown that DJ-1 is subjected to cysteine and
methionine oxidation, and the oxidative damage to DJ-1
could be associated with both PD and AD [11].
High levels of DJ-1 mRNA have been detected in neuronal
and non-neuronal populations of several regions in
mouse brain by in situ hybridization [12]. A recent study
has shown that DJ-1 expression is up-regulated in neurob-
lastoma cells exposed to rotenone or 6-hydroxy-
dopamine, which leads to the formation of intracellular
reactive oxygen species. Treatment of the mouse hippoc-
ampal cell line HT22 with H2O2 significantly increases the
immunoreactivity of DJ-1 [13]. This up-regulation of DJ-1
is suppressed when cells are pre-treated with antioxidant
[14].
Pharmacological studies have shown that DJ-1 is needed
for the protective effects of certain compounds which are
known to inhibit the production of reactive oxygen spe-
cies [15]. DJ-1 prevents oxidative stress-induced cell death
of neuroblastomas, dopaminergic cells and primary neu-
ronal cells in the presence of these compounds and knock
down (KD) of DJ-1 eliminates the suppressive effect of
these compounds [15]. Overexpression of DJ-1 was found
to decrease the expression of BAX and inhibit caspase acti-
vation, while KD of DJ-1 increased BAX protein levels, cas-
pase-3 activation and UV exposure-induced cell death. DJ-
1 has been found to directly interact with p53, and its
sumoylated form inhibits p53 transcriptional activity
[16,17]. DJ-1 also stabilizes antioxidant transcriptional
master regulator Nrf2 [18] and is involved in the pathway
that suppresses JNK1 signaling. DJ-1 was shown to
directly target MEKK1 and inhibit MEKK1 kinase activity,
and KD of DJ-1 or expression of a mutant L166P form ren-
dered cells vulnerable to death upon stress-induced acti-
vation of the MEKK1-SEK1-JNK1 signaling pathway [19].
L166P in addition to E64D, M26I, A104T, and D149A is
one of known mutations within DJ-1 that has been iden-
tified from familial PD cases. These mutant forms of DJ-1
show different levels of structural alteration (except for
E64D due to similar residue replacement), which lead to
reduced stability of DJ-1 [20,21]. The L166P form of DJ-1
has an extremely short half life, supporting the notion that
mutations in DJ-1 represent a loss-of-function mutation
[21].
DJ-1 knockout (KO) mice do not differ from wild type
mice with respect to morphology or dopaminergic cell
loss [22-24], with no dopaminergic neuronal deficit seen
even in aged DJ-1 KO mice [25]. However, isolated mito-
chondria from DJ-1 KO mice show a 2 fold increase in
H2O2, and DJ-1 appeared to function as a peroxiredoxin-
like peroxidase in these animals [23]. In zebrafish, DJ-1 is
highly conserved [26], and KD of DJ-1 causes extensive
apoptosis [27]. In Drosophila, deficiency in the functional
DJ-1 orthologous genes DJ-1α and DJ-1β (by KD and
introduction of loss-of-function mutation) renders the fly
vulnerable to paraquat-induced oxidative stress, motor
impairment and decreased life span [28].
Zebrafish are beginning to be used for aging research, e.g.,
brief exposure of zebrafish embryos with Dichlorodihy-
drofluorescein diacetate allows repeated measurement of
the level of reactive oxygen species generation in live fish
[29]. For neurodegenerative diseases, both zebrafish and
goldfish have been used to model the Parkinson's disease
[30,31]. Loss of postural reflexes and initiation of move-
ment have been replicated in part in zebrafish and gold-
fish treated by 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP), a known mitochondrial com-
plex I toxin that has been extensively used to kill DA neu-
rons in a variety of animal models for PD [32-34]. In
zebrafish and goldfish, DA neurons are found only in
forebrains. It has been proposed that some of these DA
neurons in fish forebrains are functionally analogous to
DA neurons in both mammalian forebrains and mid-
brains, especially to the mammalian midbrain ventral teg-
mental and substantia nigra area [35,36]. Therefore,
efforts have been undertaken to generate transgenic
zebrafish in which the DA-like monoaminergic neurons
are labeled by green fluorescent protein, and elimination
of DA-like neurons in zebrafish forebrains is expected to
mimic the events implicated in human PD pathogenesis
[37].
In this report, we compared KD of DJ-1 to oxidative stress
in zebrafish embryos. In addition, we examined DJ-1
expression in the adult fish brain by treating live animals
with H2O2. We found that KD of DJ-1 and H2O2 had sim-
ilar effects on islet-1 positive neurons (islet-1 is a LIM
(Lin11, Isl-1, Mec-3) homeodomain protein), with both
groups of embryos showing an increased number of apop-
totic cells. Since the oxidative stress is one of the majorPage 2 of 14
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ated DJ-1 immunoreactivity in brain sections from AD
and control cases and found a robust neuronal staining of
DJ-1 in post mortem AD brain tissues.
Methods
Fish strains
Embryos were obtained from natural spawning of wild-
type (Tubingen longfin strain) adults and were raised and
staged according to Kimmel et al. [40].
Antisense morpholino injection
DJ-1 MO, directed against the 5' untranslated region
(UTR) of DJ-1 (GeneTools, Corvallis, OR, USA) was
injected into fertilized zebrafish eggs at the one-cell stage
at which time morpholinos can rapidly spread into all
cells. The morpholino sequences were as follows: DJ-1
MO, 5'-GCGTCTAATAACCTGTGCGTGTCTG-3' control
MO, 5'-CCTCCTACCTCAGTTACAATTTATA-3'.
The above standard control MO was synthesized against
the zebrafish β-globin intron. MO oligonucleotides were
dissolved in 1× Danieu solution at 5 mM, diluted to 0.1
mM prior to injection, and ~4 ng was injected into each
embryo. After injection, embryos were incubated at
28.5°C in embryo medium [41] containing 0.002% 1-
phenyl-2 thiourea to inhibit pigment formation until they
were de-chorionated, deyolked and lysed in sample buffer
at 48 hours post fertilization (hpf) for western blot, or
fixed overnight in 4% paraformaldehyde.
TUNEL staining
TUNEL assay was performed using the TMR-RED in situ
cell death detection kit [42] according to the manufac-
turer's instructions. Optical sections were taken with a
Zeiss LMR510 confocal Microscope.
In situ hybridization and immunohistochemistry
In situ hybridization was carried out according to stand-
ard protocols [43] using a probe against zebrafish tyrosine
hydroxylase (TH). Single-stranded RNA probes against TH
from the cDNA clone in the pBluescript II KS+ vector
(from Dr. Su Guo, University of California at San Fran-
cisco, CA) was synthesized using T7 RNA polymerase after
linearization by restriction digest and then labeled with
digoxigenin-UTP (Roche, Basel, Switzerland). For immu-
nohistochemistry, standard protocols were followed
using 1% Triton X-100 in phosphate-buffered saline to
permeabilize the embryos and Vector VIP peroxidase sub-
strate kit for the colorimetric reaction (Vector Laborato-
ries, Burlingame, CA, USA). Over one dozen embryos
were examined for each experiment. The antibody 39.4D5
against islet-1 was obtained from the Developmental
Studies Hybridoma Bank maintained by The University of
Iowa.
Human postmortem cortical tissue was collected in
accordance with Institutional Review Board-approved
guidelines at Brigham and Women's hospital. Blocks of
cortex were fixed for ~2 hrs in 10% neutral buffered for-
malin, as previously described [44]. Paraffin-embedded 8
μm serial sections were blocked for 1 hr in 10% goat
serum (for polyclonal DJ-1-N), 10% rabbit serum (for
polyclonal Park7), or 10% horse serum (for monoclonal
KAM-SA100 or E2.19) and incubated overnight at 4°C
with primary antibodies DJ-1-N (1:50), Park7 (1:100,
against C-terminus of DJ-1, from Abcam), KAM-SA100
(1:100, against full length DJ-1, from Stressgen), E2.19
(1:100, against full length DJ-1, from Dr. Y. Hod and
Abcam)[45]. For preabsorption, 5 μg of DJ-1 peptide per
μl of DJ-1 serum was used. For double immunofluores-
cence, rabbit polyclonal anti-GFAP (1:500, Dako) and DJ-
1-N (1:50) were used.
Western blotting
Human, mouse and zebrafish brain samples were homog-
enized in lysis buffer containing 0.2% NP-40. The lysates
were collected after 1 hr of centrifugation at 100 000 × g
(human and mouse) or after 5 min of centrifuge at 18,000
× g (zebrafish). Individual de-chorionated and de-yolked
embryos were lysed, and all samples were heated in 1 ×
sample buffer (3% sodium dodecyl sulfate, 3% β-mercap-
toethanol, 15% glycerol, and bromophenol blue) and
then separated by sodium dodecyl sulfate polyacrylamide
gel electrophoresis. Antibodies KAM-SA100 (1:1000,
Stressgen) and anti-DJ-1-N (1:500) and an enhanced
chemiluminescence system (Amersham, Piscataway, NJ,
USA) were used to detect the western blots.
Exposure of Aβ in cultured cells
Wildtype CHO cells and APP stably transfected CHO cells
(CHO+APP) were grown for 24 hrs before the condi-
tioned media were collected for the measurement of Aβ
levels by ELISA, as previously described [46]. The same
conditioned media were applied to PC-12 cells for 24 hr,
and cells were collected for the quantification of DJ-1 by
Western blot using antibody DJ-1-N.
Results
Detection of human and zebrafish DJ-1
We generated an affinity purified polyclonal antibody DJ-
1-N against the N-terminus of DJ-1 that recognizes a sin-
gle band at 23 kDa corresponding to endogenous DJ-1
from human cortex homogenate; this band was absent
when the antibody was preabsorbed with its cognate pep-
tide (Fig. 1A). The same band was recognized by a com-
mercially available monoclonal antibody (KAM-SA100)
raised against full-length human recombinant DJ-1 (Fig.
1A). We further tested the specificity of this antibody by
Western blotting of brain homogenate from a wild type or
DJ-1 knockout mouse. Using the antibody DJ-1-N wePage 3 of 14
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not DJ-1 knockout mouse brain lysates (Fig. 1A). We then
prepared zebrafish embryos at different developmental
stages as well as brain lysates from adult zebrafish for
Western blotting using another commercially available
monoclonal antibody E2.19 (Fig. 1B). Staining of
zebrafish lysates with DJ-1-N showed the same results
(data not shown). We found that DJ-1 was expressed early
Knockdown of DJ-1 in zebrafish embryosFigure 1
Knockdown of DJ-1 in zebrafish embryos. A. Abundant DJ-1 expression in human brain lysate from a control case, as 
detected by Western Blot (WB) with KAM-SA100 and anti-DJ-1-N antibodies, but not when anti-DJ-1-N was pre-absorbed 
with the synthetic DJ-1 peptide. Specificity of anti-DJ-1-N antibody was confirmed by detecting DJ-1 in wild type mouse brain 
lysate but not in the DJ-1 knockout mouse brain lysate. A minor cross-reacting band at ~70 kDa was detected in extracts of 
both wild type and DJ-1 knockout mouse brain, but not in human brain extracts. B. Zebrafish embryos at different develop-
mental stages and brains of adult zebrafish were lysed for Western blotting with antibody E2.19. High levels of DJ-1 protein 
were found in embryos at all developmental stages and in adult brains. C. Extracts taken from individual embryos at 24 hpf 
were run on WB with antibody E2.19 (bottom panel). The same blot was re-probed with antibody against α-tubulin (top 
panel). DJ-1 protein levels were dramatically reduced in DJ-1 KD embryos compared to control embryos.
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(Fig. 1B).
Knockdown of DJ-1 in zebrafish embryos
Using the human DJ-1 sequence, we identified multiple
zebrafish ESTs and obtained the complete zebrafish DJ-1
sequence by the alignment of these ESTs with genomic
zebrafish DJ-1 sequences from the Sanger Institute. We
only found one DJ-1 homologue in zebrafish. Zebrafish
DJ-1 has 4 exons that encode 189 amino acids, and the
protein is 87% homologous to human DJ-1. cDNA from
zebrafish embryos at the 1-somite stage was prepared and
the full-length zebrafish DJ-1 cloned. The sequence of
cDNA was confirmed and found to be identical to the one
previously reported [27].
A morphant technology that uses morpholino phos-
phodiamidate anti-sense oligonucleotides (morpholinos,
MO) to target genes in vivo [47-49] was used to knock
down DJ-1. We used a stock concentration of 0.5 mM MO
targeting DJ-1 and injected DJ-1 MO into embryos at the
1-cell stage. In all experiments, DJ-1 MO injected embryos
were compared to embryos injected with a standard con-
trol MO targeting the β-globin intron. To confirm the
reduction of DJ-1 protein, we examined protein extracts
from these embryos at 48 hours post fertilization (hpf) on
Western blots (Fig. 1C). DJ-1 was similarly reduced in
individual embryos injected with DJ-1 MO compared to
control MO injected embryos. The same blot was probed
with antibody against α-tubulin as a loading control.
Since we transiently knocked down DJ-1 expression, it
was different from DJ-1 null animal, as we failed to see a
lasting effect of DJ-1 morpholino at 72 hpf (data not
shown). In contrast to DJ-1 null mouse which was used
for our antibody characterization (Fig. 1A), a lack of DJ-1
null zebrafish prevents us from analyzing animals at later
development and adult stages. However, although DJ-1
MO did not completely eliminate DJ-1, the reduction of
DJ-1 protein was prominent and consistent among all
injected embryos at 48 hpf, the time point when we per-
formed all analyses.
DJ-1 expression is induced in zebrafish under oxidative 
stress and retains cell survival
Both control and DJ-1 MO injected embryos shared an
almost identical morphology (Fig. 2A), and no dramatic
change in phenotype was observed in DJ-1 MO injected
embryos (Fig. 2B). Since a loss of DJ-1 in humans leads to
PD that is characterized in part by a gradual loss of tyro-
sine hydroxylase (TH)-positive dopaminergic neurons, we
examined the expression of TH in zebrafish embryos by in
situ hybridization. We failed to observe any alteration in
TH staining in the DJ-1 KD embryos compared with con-
trol MO injected embryos at 48 hpf (Fig. 2C, D) suggest-
ing that formation of dopaminergic like neurons in
zebrafish was not affected by a loss of DJ-1 protein.
We further examined islet-1 positive primary neurons that
play an important role during zebrafish neural develop-
ment. After control and MO injected embryos were fixed
at 48 hpf, we carried out immunostaining using an anti-
body against islet-1, as we have previously reported [50].
We also treated control embryos with 0.03% H2O2 to
induce an environment of oxidative stress. We found that
control MO injected embryos showed well defined islet-1
positive neurons along the spinal cord (Fig. 3A). In the
presence of H2O2, staining in control DJ-1 injected
embryos was slightly reduced, but islet-1 positive cells
could still be identified (Fig. 3B). Similarly, DJ-1 KD
embryos showed weak staining of islet-1 positive cells
(Fig. 3C).
When the same set of embryos was examined for the pres-
ence of apoptotic cells by TUNEL staining, control MO
DJ-1 expression is not essential for proper zebrafish develop-mentFigure 2
DJ-1 expression is not essential for proper zebrafish 
development. A, B. Embryos were injected with control or 
DJ-1 MO at the one cell stage, and images were acquired at 
48 hpf. DJ-1 KD fish did not differ in morphologic phenotype 
compared to control MO injected zebrafish. C, D. Embryos 
injected with control or DJ-1 MO were fixed at 48 hpf, fol-
lowed by in situ hybridization using a probe against TH. TH 
staining of control or DJ-1 MO injected embryos was almost 
identical.
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but the treatment of these embryos with H2O2 increased
the number of apoptotic cells (Fig. 3E). A similar result
was obtained in DJ-1 KD embryos, which showed
increased TUNEL staining, i.e., an increased number of
apoptotic cells (Fig. 3F).
Since we found that DJ-1 was expressed throughout devel-
opment and into adulthood (Fig. 1B), we explored the
regulation of DJ-1 expression in adult fish under a stress-
ful condition, such as oxidative stress. We created an envi-
ronment of oxidative stress by exposing adult fish to
0.03% H2O2 in their tank water. We found increased lev-
DJ-1 expression is induced in zebrafish treated with H2O2 and knockdown of DJ-1 increases the number of apoptotic cellsFigure 3
DJ-1 expression is induced in zebrafish treated with H2O2 and knockdown of DJ-1 increases the number of 
apoptotic cells. A. Control MO injected embryos showed normal distribution of islet-1 positive neurons along the spinal 
cord, as illustrated by the dorsal view of the spinal cord, anterior to the top of the image. B. Control MO injected embryos 
treated with H2O2 showed a slight reduction in islet-1 staining. C. DJ-1 MO injected embryos displayed even weaker islet-1 
staining. D-F. Control MO (D, E) or DJ-1 MO (F) was injected into embryos at one cell stage; after 24 hr, control MO injected 
embryos were treated with 0.03% H2O2 for 30 min. Compared to control MO injected embryos (D), there was an increase of 
TUNEL positive cells in the tails of H2O2 treated embryos (E) and DJ-1 MO injected embryos (F). The lateral view of the trunk 
region of zebrafish was illustrated with anterior to the left of the image. The number of apoptotic cells in the tails of H2O2 
treated embryos (E) and DJ-1 KD embryos (F) is higher than that in control MO injected embryos (D). G. Adult zebrafish were 
treated with 0.03% H2O2 for 30 min before brains were harvested and lysed for Western blot. α-Tubulin (an internal sample 
loading control) was detected over the upper portion of the blot, and the bottom portion of the blot was detected with anti-
body DJ-1-N. While the levels of α-tubulin were not changed in the presence of H2O2, the levels of DJ-1 were increased.
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to 0.03% H2O2 compared with fish from the control envi-
ronment (Fig. 3G).
DJ-1 is expressed in pyramidal neurons in AD hippocampus
Because oxidative stress is one of the major contributors to
AD [38,39], we examined whether up-regulation of DJ-1
occurred in human brains undergoing a neurodegenera-
tive process. We analyzed brain tissue from individuals
with well-defined cases of AD. DJ-1 was examined in
briefly fixed hippocampal sections from postmortem AD
brains using our newly generated, affinity purified DJ-1-N
antibody (Fig. 4A) (n = 10, age range: 77–92, Braak Stage:
III-VI) [51] and non-demented control cases (n = 9, age
range; 52–91). The intensity of the staining was variable
among the AD cases, although it did not seem to correlate
with the severity of the disease based on Braak staging [51]
(data not shown). There was an absence of staining when
the DJ-1-N antibody was preabsorbed with synthetic DJ-1
peptide prior to incubation on sections (Fig. 4B) and
DJ-1 is detected in neurons from briefly fixed post mortem AD brainsFigure 4
DJ-1 is detected in neurons from briefly fixed post mortem AD brains. A. Affinity purified antibody DJ-1-N detected 
neurons in brain section from AD cases. Staining was observed in pyramidal neurons of CA1, CA2 and CA3 subregions. B. 
Absence of staining in AD brain with anti-DJ-1-N preabsorbed with DJ-1 peptide, compared to an adjacent section immunos-
tained with anti-DJ-N (A). C. DJ-1 immunoreactivity in a briefly fixed (~2 hours) section was easily detected. D. DJ-1-N failed 
to stain a routinely fixed (~2–4 weeks) section from the same AD case. E-G, Co-Staining of DJ-1 and GFAP in astrocytes of 
human brain sections. A routinely fixed section from control brain was stained with antibody DJ-1-N (E) and GFAP (F). Double 
immunofluorescent overlay indicates the location of DJ-1 in astrocytes (G). Magnification: A, B = 40×; C, D = 20×.
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Brief fixation (< 2 hours) (Fig. 4C), as opposed to long-
term fixation (2–4 weeks) (Fig. 4D) was critical for opti-
mal neuronal DJ-1 immunostaining. We also explored DJ-
1 expression in astrocytes. Double immunofluorescence
labeling with anti-DJ-1-N (Fig. 4E) and anti-GFAP anti-
body (Fig. 4F) further confirmed the presence of DJ-1 in
astrocytes (Fig. 4G).
Similar to DJ-1-N (Fig. 5A), three commercially available
DJ-1 antibodies, E2.19 (Fig. 5C), KAM-SA100 (Fig. 5E),
and Park7 (Fig. 5G) were able to detect DJ-1 in neurons in
adjacent sections of the same AD patient, but the staining
was much weaker. Anti-DJ-1-N (Fig. 5B), E2.19 (Fig. 5D),
and KAM-SA100 (Fig. 5F) detected astocyte DJ-1 in
briefly, as well as, routinely fixed sections, with Park 7
showing much less staining (Fig. 5H).
Control brains (n = 9) also showed DJ-1 immunoreactiv-
ity in scattered astrocytes (data not shown), but they
showed weak or no DJ-1 staining in pyramidal neurons of
the CA1, CA2, CA3 sub-regions and the hilus of the den-
tate gyrus (CA4) (Fig. 6A, B), except for one case (C2,
Table 1). In AD brains, 6 out of 10 cases showed moderate
to abundant staining of DJ-1 (Table 1). DJ-1 immunore-
activity was observed in pyramidal neurons (cytoplasm
and neuronal processes) of CA1–4 regions (Fig. 6C, D).
Examination of other cortical areas revealed DJ-1 immu-
nopositive neurons in the enthorinal cortex, frontal lobe
and occipital lobe (data not shown). The staining for DJ-
1 in brain sections from control and AD subjects was sum-
marized in Table 1.
To search for any mechanistic cause for DJ-1 expression in
AD brains, we examined the effect of Aβ on the regulation
of DJ-1 expression. We have used two cell lines, CHO that
expresses endogenous levels of APP, and CHO+APP that
expresses high levels of APP and generates a large amount
of Aβ. When we measured the conditioned media from
CHO and CHO+APP cells, we found elevated levels of
Aβ40 (Fig. 7A, before treatment) and Aβ42 (Fig. 7B,
before treatment) in the media from CHO+APP cells,
compared to undetectable level of Aβ in the media from
CHO cells (Fig. 7A and 7B). We applied conditioned
media to PC-12 cells for 24 hrs, and collected media and
cells for the quantification of Aβ and DJ-1. We found that
the conditioned media continued to carry high levels of
Aβ40 (Fig. 7A, after treatment) and Aβ42 (Fig. 7B, after
treatment). Despite of the Aβ exposure, the expression lev-
els of DJ-1 in PC-12 cells maintained at similar levels (Fig.
7C). Therefore, endogenous DJ-1 expression in PC-12
cells did not change in the presence of extracellular Aβ.
Discussion and conclusion
It is known that oxidative stress and mitochondrial dys-
function contribute to the pathogenesis of AD and PD. In
AD, Aβ may directly interact with mitochondria and lead
to increased free radical production; in PD, DJ-1, parkin
and PINK1 are all linked to oxidative stress and/or mito-
chondrial dysfunction {Reviewed by [52,53]}. In this
study, we aimed to examine the relationship between DJ-
1 and oxidative stress in zebrafish and also explore the
spatial association of DJ-1 to neurons in AD brains.
Consistent with earlier studies in DJ-1 KO mice [22-24],
KD of DJ-1 in zebrafish embryos did not result in a change
in TH expression {[27] and this study}. Previous studies
have focused on pharmacologic treatment of zebrafish to
reduce the number of DA-like neurons in zebrafish, e.g.,
MPTP, rotenone, and paraquat [34]. Extensive loss of DA
neurons found in human forebrains and midbrains are
responsible for most symptoms that are observed in PD
patients, as these DA neurons control postural reflexes
and initiation of movement. Genetic ablation of DA neu-
rons becomes possible in light of a successful creation of
a transgenic zebrafish expressing GFP in DA-like
monoaminergic neurons [37]. Results from our study sug-
gest that knocking down DJ-1 alone is not sufficient to
reduce TH-positive DA-like neurons in zebrafish. Instead,
a combination of DJ-1 knockdown/knockout and neuro-
nal insult is needed to model pathogenesis in brains of
zebrafish. Comparing embryos injected with control MO
and those injected with DJ-1 MO, a slightly reduced stain-
ing of islet-1 positive neurons was observed in the latter
group. Islet-1 expresses at the earliest stage of neural dif-
ferentiation. It is highly conserved during evolution, and
is expressed in the many functional classes of primary
neurons at 24 hpf [54-58]. The decrease in the number of
islet-1 positive cells in the DJ-1 KD embryos was not high
enough to cause abnormal neuronal development, with
the DJ-1 MO injected embryos showing hardly any mor-
phologic difference compared to the control MO injected
embryos {[27] and this study}.
We found that DJ-1 KD embryos have an increased
number of apoptotic cells, consistent with an earlier
report showing a p53 dependent apoptosis in DJ-1 KD
zebrafish embryos [27]. In cultured cells, DJ-1 directly
interacts with p53 to inhibit its transcriptional activity
[16]. Since knocking down DJ-1 increases BAX protein
levels and caspase-3 activation in cultured cells, knocking
down DJ-1 in zebrafish likely undergoes similar pathways
that lead to enhanced apoptosis. Another pathway that
may be activated in the absence of DJ-1 is the MEKK1-
SEK1-JNK1 signaling pathway, as DJ-1 has been shown to
directly target MEKK1 and inhibit MEKK1 kinase activity
[19]. Knocking down DJ-1 may trigger this pathway
thereby increasing the number of apoptotic cells.Page 8 of 14
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DJ-1 is detected in both neurons and astrocytes by multiple antibodiesFigure 5
DJ-1 is detected in both neurons and astrocytes by multiple antibodies. Antibody DJ-1-N (A) has stronger neuronal 
staining than three commercially available DJ-1 antibodies, E2.19 (C), KAM-SA100 (E), and Park7 (G) that also detected DJ-1 in 
neurons in all adjacent briefly fixed sections of the same AD patient. DJ-1-N (B), E2.19 (D), and KAM-SA100 (F) detected 
immunoreactivity in astrocytes in routinely fixed sections, and Park7 showed a much weaker staining of astrocytes (H). Magni-
fication: 20×.
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Molecular Neurodegeneration 2009, 4:12 http://www.molecularneurodegeneration.com/content/4/1/12Recent studies have shown that DJ-1 expression is up-reg-
ulated in cultured cells in an environment that promotes
the formation of intracellular reactive oxygen species
[13,14]. We have studied the effects of high levels of H2O2
on DJ-1 expression in the brains of adult zebrafish in vivo.
For the first time, we found an increase in DJ-1 protein in
brains of adult fish subjected to a stressful environment
such as oxidative stress. While it is difficult to discern
whether the increase in DJ-1 was derived from neuronal
or glial sources, we predict that it was a global response
from exposure to H2O2 in the environment.
To further address this relationship, we utilized brain sec-
tions from post mortem AD and control subjects. We
found that the avidity of different antibodies and the
methods for preserving brain tissues were critical for
revealing DJ-1 immunostaining. Whereas antibodies
raised against the C-terminus of DJ-1 (Park7) [8,9] or full-
Enhanced immunostaining of DJ-1 in AD but not control brainsFigure 6
Enhanced immunostaining of DJ-1 in AD but not control brains. A, B. control brains (n = 9) showed weak or no DJ-1 
staining in pyramidal neurons of the CA1, CA2, CA3 sub-regions and the hilus of the dentate gyrus (CA4). C, D. AD brains (n 
= 6/10) showed DJ-1 immunoreactivity in pyramidal neurons (cytoplasm and neuronal processes) of CA1–4 regions. Magnifica-
tion: A, C = 4×; B, D = 40×.
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Molecular Neurodegeneration 2009, 4:12 http://www.molecularneurodegeneration.com/content/4/1/12length DJ-1 (KAM-SA100 and E2.19) [7,8] predominantly
detect reactive astrocytes with less robust neuronal stain-
ing, our N-terminal DJ-1-N antibody efficiently stained
both astrocytes and pyramidal neurons. The specificity of
our affinity purified DJ-1-N was demonstrated by our
comparison of tissue lysates from wild type and DJ-1 KO
mouse brains. Furthermore, DJ-1-N only detected a single
band on our Western blot of human brain lysates. There-
fore, immunostaining of human brain sections with DJ-1-
N was highly specific, and the robust signals from AD
brain sections represent high levels of DJ-1 protein in
these neurons.
Our comparison staining with DJ-1-N and other DJ-1
antibodies (E2.19, KAM-SA100 and Park7) reveals an
important finding on the potential binding region of DJ-
1 when it dimerizes. Earlier reports, including ours, have
demonstrated that DJ-1 dimerizes and forms a high
molecular weight complex in cultured cells and human
brains [21,59]. It seems that the mid- and C-terminal
regions of DJ-1 could be involved in dimerization and are
no longer accessible by antibodies that recognize these
regions. However, the N-terminal region of DJ-1 may still
be exposed and not involved in binding in the dimer or
high molecular weight complex. DJ-1-N may therefore
efficiently detect the exposed antigen in brain sections.
Table 1: Summary of DJ-1 Staining in Brains from Control and 
AD Subjects
Subject sex age Diagnosis DJ-1
C1 F 76 control -
C2 M 52 control ++
C3 M 53 control -
C4 F 72 control -
C5 M 70 control -
C6 F 60 control -
C7 M 64 control -
C8 M 73 control -
C9 M 91 control -
A1 M 77 AD -
A2 F 91 AD -
A3 F 81 AD ++
A4 F 88 AD +
A5 M 78 AD ++
A6 M 78 AD ++++
A7 F 92 AD ++
A8 F 84 AD ++
A9 F 86 AD -
A10 F 80 AD ++
Note: -, none; +, low; ++, moderate; +++, high; ++++, abundant.
Lack of changes in DJ-1 expression in the presenceof AβFigure 7
Lack of changes in DJ-1 expression in the presenceof 
Aβ. Conditioned media from CHO and CHO+APP cells 
were collected for the measurement of Aβ levels and treat-
ment of PC-12 cells. A. High levels of Aβ40 were found in 
the media from CHO+APP cells before (white bar) and after 
(black bar) the treatment of PC-12 cells (the standard error 
of means was illustrated). B. High levels of Aβ42 were found 
in the media from CHO+APP cells before (white) and after 
(black) the treatment of PC-12 cells, compared to undetecta-
ble amount of Aβ in the media from CHO cells. C. Condi-
tioned media from CHO or CHO+APP cells were applied to 
PC-12 cells for 24 hr, and cells were collected for the quanti-
fication of DJ-1 by Western blot using antibody DJ-1-N. Cells 
from two independent experiments were collected, and the 
expression levels of DJ-1 in both sets of PC-12 cells main-
tained at similar levels.
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Molecular Neurodegeneration 2009, 4:12 http://www.molecularneurodegeneration.com/content/4/1/12This finding is identical to what we have found in Aβ dim-
ers, where N-terminal antibodies more effectively capture
dimeric Aβ compared to antibodies recognizing mid- and
C-terminal regions of Aβ [46]. Whether the N-terminus of
DJ-1 is somehow altered during long term fixation is not
clear, as strong staining of DJ-1 only in briefly fixed brain
sections suggests that the method of preserving post mor-
tem brains plays an important role.
The intriguing finding of positive staining of DJ-1 in AD
brains but not control brains has important implications
for both PD and AD pathogenesis. In brains of AD
patients, the neuritic plaque composed of Aβ is one of the
major characteristics of AD pathology. A lack of change in
DJ-1 expression in cultured cells exposed to high levels of
Aβ suggests that Aβ has no direct effect on steady state lev-
els of DJ-1. During the neurodegenerative process, accu-
mulation of reactive oxygen species renders neurons, such
as pyramidal neurons around hippocampal area,
extremely vulnerable, and gradual neuronal loss is inevi-
table when the brain is exposed to insults. The fact that DJ-
1 itself is subjected to cysteine and methionine oxidation
[11] as well as the increment of DJ-1 expression in
zebrafish under oxidative stress provides important clues
to our findings in human brains. It seems that the dam-
aged DJ-1 failed to prevent oxidative stress-induced grad-
ual neuronal death when neurons in AD brains were
exposed to an environment with high levels of reactive
oxygen species. In certain areas of the brain in AD
patients, levels of functional DJ-1 may be reduced, leading
to neuronal death. Under these conditions, human brain
may respond with an increased expression of DJ-1, like
zebrafish exposed to H2O2. Therefore, the similarity of
increased DJ-1 staining in H2O2 treated zebrafish and AD
brains suggest that a common pathway might be elicited
under damaging conditions. As previously reported, DJ-1
is needed to avoid oxidative stress-induced cell death in
cultured neuroblastomas, dopaminergic cells and primary
neuronal cells [60]. Therefore, our results suggest that sur-
viving neurons found in AD hippocampus expressed high
levels of DJ-1 in response to a damaging environment,
whereas in control brains few exogenous factors induced
the expression of DJ-1.
Furthermore, DJ-1 is a non-traditional peroxiredoxin-like
peroxidase [23], and enhanced levels of DJ-1 in pyramidal
neurons in AD brain may simply represent a response to
an accumulation of reactive oxygen species in the mito-
chondria. This is supported by the finding that mitochon-
dria isolated from DJ-1 KO mice have increased levels of
H2O2 [23].
Future studies are necessary to characterize the role of DJ-
1 in PD and AD pathogenesis such as whether the DJ-1
protein we found in pyramidal neurons in AD hippocam-
pus is an acidic isoform [10], basic isoform [11], or both.
A specific isoform of DJ-1 may lose its protective role in
neuronal survival while oxidation of cysteine/methionine
in DJ-1 may lead to a detrimental effect on neurons. The
novel finding of an increased DJ-1 expression in zebrafish
treated with H2O2 illustrates a new plate form that allows
us to examine the role of DJ-1 involved in response to oxi-
dative stress. Investigation of the function/dysfunction of
DJ-1 in a whole vertebrate animal exposed to a stressful
environment has a direct physiological relevance to
human diseases. Therefore, exploring mechanisms of DJ-
1 associated with PD and AD pathogenesis will provide
insight into common pathways involved in both neurode-
generative diseases. Any newly identified pathways will
offer novel drug targets and exciting opportunities for
therapeutic intervention.
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